DENVER, CO—For patients receiving optimal medical therapy, stenting a chronic total occlusion (CTO) does not provide a boost in either regional or global LV function, the REVASC trial shows. The ...
Alongside a strategy of subintimal tracking and re-entry, bringing patients back for stenting—early or late—offers similar ...
We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. In patients who undergo PCI for STEMI, additional PCI ...
We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Back to Healio Chronic total occlusion is commonly ...
Chronic total occlusion PCI may reduce mortality, but randomized trial is still at least a year away
Quebec City - A new meta-analysis of observational studies published in the July 2010 issue of the American Heart Journal suggest that recanalization of coronary chronic total occlusions (CTOs) with a ...
In patients undergoing chronic total occlusion (CTO) percutaneous coronary intervention (PCI), stenting demonstrated improved long-term survival and fewer cardiac arrests at one year. The ...
Share on Facebook. Opens in a new tab or window Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window WASHINGTON -- ...
Study Will Evaluate the Performance of Teleflex Coronary Guidewires and Specialty Catheters in Patients Undergoing Chronic Total Occlusion Percutaneous Coronary Interventions WAYNE, Pa., June 02, 2020 ...
ATLANTA, GA (May 20, 2022) – A new analysis of PROGRESS-CTO (PROspective Global REgiStry for the Study of Chronic Total Occlusion Intervention; www.progresscto.org), an international multi-center ...
Enrollment Completed Ahead of Schedule in Study Evaluating the Performance of Teleflex Specialty Catheters and Coronary Guidewires in Patients Undergoing Chronic Total Occlusion Percutaneous Coronary ...
PARIS — Findings from the prospective Consistent CTO study offer a bit of optimism for complex chronic total occlusion (CTO) percutaneous coronary intervention (PCI) in highly symptomatic patients. In ...
WAYNE, Pa., June 02, 2020 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE: TFX), a leading global provider of medical technologies, today announced the first patient enrollment in a clinical study ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback